Fed. Circ. Ruling Blunts On-Sale Bar's Threat To Patents
The full Federal Circuit's decision Monday that outsourcing manufacturing does not necessarily trigger the on-sale bar in patent cases aids drugmakers and others that cannot make products in-house, discarding a prior...To view the full article, register now.
Already a subscriber? Click here to view full article